[1] R. Argarwal, G.S. Shukla, Potential role of cerebral glutathione in
the maintenance of blood–brain barrier integrity in rat, Neurochem. [22]
Res. 24 (1999) 1507–1514.
[2] P.A. Baeuerle, V.R. Baichwall, NF-k B as a frequent target for [23]
immunosuppressive and anti-inflammatory molecules, Adv. Im- munol. 65 (1997) 111–137.
[3] A.S. Baldwin Jr, The NF-k B and I k-B proteins: new discoveries [24]
and insights, Annu. Rev. Immunol. 14 (1996) 649–683.
[4] T.I. Belova, G. Johnsson, Blood brain barrier permeability and
immobilisation stress, Acta Physiol. Scand. 116 (1982) 21–29.
[5] K.M.K. Boje, S.S. Lakhman, Nitric oxide redox species exert [25]
differential permeability effects of the blood–brain barrier, J.
Pharmacol. Exp. Ther. 293 (2000) 545–550.
[6] N.K. Cortas, N.W. Wakid, Determination of inorganic nitrate in
serum and urine by a kinetic cadmium-reduction method, Clin.
Chem. 36 (1990) 1440–1443. [26]
[7] W.D. Dietrich, O. Alonso, M. Halley, R. Busto, M.Y.-T. Globus,
Intraventricular infusion of N-methyl-D-aspartate. I: acute blood–
brain barrier consequences, Acta Neuropathol. 84 (1992) 621–629.
[8] A.J. Dunn, J. Wang, T. Ando, Effects of cytokines on cerebral [27]
neurotransmission. Comparison with the effects of stress, Adv. Exp.
Med. Biol. 461 (1999) 117–127.
[9] E.P. Garvey, J.A. Oplinger, E.S. Furfine, R.J. Kiff, F. Laszlo, B.R.J. [28]
Whittle, R.G. Knowles, 1400W is a slow, tight binding, and highly
selective inhibitor of inducible nitric oxide synthase in vitro and in
vivo, J. Biol. Chem. 272 (1997) 4959–4963.
[10] L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Whis- [29]
15
hnok, S.R. Tannenbaum, Analysis of nitrate, nitrite and [ N] in
biological fluids, Anal. Biochem. 126 (1982) 131–138.
